Intron A; Interferon Alfa-2B Recombinant, 25 million IU

Social Media Share Tools

Object Details

Schering Corporation

Description (Brief): Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.; Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.; Object consists of a cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
Location: Currently not on view

Credit Line: Gift of Schering Corporation, through Steven Schneider, Vice-President

Physical Description: interferon alfa-2b recombinant (overall material); glycine (overall material); sodium phosphate dibasic (overall material); paper (container material); glass (container material)
Measurements: overall: 8.8 cm x 6.2 cm x 3.5 cm; 3 7/16 in x 2 7/16 in x 1 3/8 in; overall: 3 1/2 in x 2 3/8 in x 1 3/8 in; 8.89 cm x 6.0325 cm x 3.4925 cm

See more items in: Medicine and Science: Medicine; Health & Medicine; The Antibody Initiative; Biotechnology and Genetics; Recombinant Pharmaceuticals; Science & Mathematics; Antibody Initiative: Monoclonal Antibodies

National Museum of American History

GUID (Link to Original Record): http://n2t.net/ark:/65665/ng49ca746a9-3503-704b-e053-15f76fa0b4fa